Anaptysbio (ANAB) Shares Outstanding (Weighted Average) (2016 - 2026)

Anaptysbio has reported Shares Outstanding (Weighted Average) for 11 years, with the latest figure at $28.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 6.37% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $28.7 million (down 6.37% YoY), and the FY2025 full-year result was $28.8 million, up 1.32% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $28.7 million, roughly flat from $28.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $30.6 million in Q1 2025, with the low at $26.8 million in Q1 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $28.0 million across 5 years, with a median of $28.0 million in 2023.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) increased 14.34% — and 2026, when it fell 6.37%.
• Anaptysbio's Shares Outstanding (Weighted Average) stood at $28.2 million in 2022, then retreated by 4.41% to $26.9 million in 2023, then advanced by 5.42% to $28.4 million in 2024, then climbed by 1.32% to $28.8 million in 2025, then decreased by 0.23% to $28.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.7 million (Q1 2026), $28.8 million (Q4 2025), and $27.8 million (Q3 2025), per Business Quant data.